Bowhead Specialty (NYSE:BOW) Given New $30.00 Price Target at JPMorgan Chase & Co.

Bowhead Specialty (NYSE:BOW) had its price objective upped by JPMorgan Chase & Co. from $26.00 to $30.00 in a research note released on Thursday,Benzinga reports. The firm currently has a neutral rating on the stock.

Several other research analysts also recently issued reports on the stock. Keefe, Bruyette & Woods upped their price target on shares of Bowhead Specialty from $30.00 to $33.00 and gave the stock a “market perform” rating in a report on Tuesday, October 29th. Royal Bank of Canada upped their target price on Bowhead Specialty from $32.00 to $35.00 and gave the stock an “outperform” rating in a report on Wednesday. Finally, JMP Securities boosted their price target on Bowhead Specialty from $32.00 to $33.00 and gave the stock a “market outperform” rating in a report on Wednesday. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, Bowhead Specialty presently has an average rating of “Hold” and an average price target of $31.40.

Bowhead Specialty Price Performance

Shares of NYSE:BOW traded up $0.34 on Thursday, hitting $32.83. The company had a trading volume of 345,989 shares, compared to its average volume of 186,889. Bowhead Specialty has a 1-year low of $22.14 and a 1-year high of $33.85. The stock’s 50 day moving average is $29.50.

Bowhead Specialty (NYSE:BOW) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $0.38 earnings per share for the quarter, hitting the consensus estimate of $0.38. The firm had revenue of $116.76 million for the quarter, compared to the consensus estimate of $113.00 million. As a group, equities research analysts expect that Bowhead Specialty will post 1.3 earnings per share for the current year.

Insider Buying and Selling at Bowhead Specialty

In other news, Director Family Mutual Insuran American sold 1,362,285 shares of the business’s stock in a transaction that occurred on Friday, October 25th. The shares were sold at an average price of $27.70, for a total value of $37,735,294.50. Following the transaction, the director now owns 4,700,761 shares in the company, valued at approximately $130,211,079.70. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Institutional Trading of Bowhead Specialty

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BOW. Victory Capital Management Inc. raised its holdings in Bowhead Specialty by 4.5% during the third quarter. Victory Capital Management Inc. now owns 658,595 shares of the company’s stock worth $18,447,000 after buying an additional 28,235 shares during the last quarter. Emerald Advisers LLC raised its stake in shares of Bowhead Specialty by 3.3% in the third quarter. Emerald Advisers LLC now owns 242,633 shares of the company’s stock worth $6,796,000 after purchasing an additional 7,683 shares during the last quarter. Emerald Mutual Fund Advisers Trust lifted its stake in Bowhead Specialty by 0.5% during the 3rd quarter. Emerald Mutual Fund Advisers Trust now owns 194,333 shares of the company’s stock valued at $5,443,000 after acquiring an additional 937 shares in the last quarter. Cubist Systematic Strategies LLC bought a new stake in shares of Bowhead Specialty in the 2nd quarter worth $385,000. Finally, Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Bowhead Specialty during the second quarter valued at about $192,000.

About Bowhead Specialty

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.